NCT02344121 Intra- and Inter-fraction Changes in Radiation Therapy
| NCT ID | NCT02344121 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical College of Wisconsin |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2015-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2015-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Analysis to quantify intra-fraction, inter-fraction and post-treatment changes in tumor target volumes and surrounding normal organs in radiation therapy.
Eligibility Criteria
Inclusion Criteria: °Completed radiation therapy Exclusion Criteria: °Subjects who refuse voluntary participation
Contact & Investigator
Eric Paulson, PhD
PRINCIPAL INVESTIGATOR
Medical College of Wisconsin
Frequently Asked Questions
Who can join the NCT02344121 clinical trial?
This trial is open to participants of all sexes, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02344121 currently recruiting?
Yes, NCT02344121 is actively recruiting participants. Contact the research team at cccto@mcw.edu for enrollment information.
Where is the NCT02344121 trial being conducted?
This trial is being conducted at Milwaukee, United States.
Who is sponsoring the NCT02344121 clinical trial?
NCT02344121 is sponsored by Medical College of Wisconsin. The principal investigator is Eric Paulson, PhD at Medical College of Wisconsin. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.